lasmiditan
Ligand Summary
Reyvow (lasmiditan) is a serotonin (5-HT) 1F receptor agonist for oral administration, bindinding with high affinity to the 5-HT1F receptor. Lasmiditan presumably exerts its therapeutic effects in the treatment of migraine through agonist effects at the 5-HT1F receptor; however, the precise mechanism is unknown.
UNII: 760I9WM792
PubChem: 11610526
Guide to Pharmacology: 3928
ChEMBL: CHEMBL3039520
DrugCentral: 5351
LyCHI: 9KXL97MJ25JM
Target Activities
3 Activities
Items per page:
10
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
- | ||||||
IC50 | ||||||
Ki | AGONIST | |||||